The global leukemia therapeutics treatment market is expected to grow at a CAGR of 6.6% during the forecast period (2025–2035). Factors such as the rising prevalence of leukemia, increasing adoption ...
In early UK corporate news, Phoenix Group lifted its 2026 profit outlook after meeting a cash generation goal sooner than expected. AstraZeneca announced a USD1 billion acquisition. Elsewhere, there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback